Literature DB >> 1346735

Analysis of proliferating hepatocytes using a monoclonal antibody against proliferating cell nuclear antigen/cyclin in embedded tissues from various liver diseases fixed in formaldehyde.

N Kawakita1, S Seki, H Sakaguchi, A Yanai, T Kuroki, Y Mizoguchi, K Kobayashi, T Monna.   

Abstract

The authors studied histochemically the morphologic features of proliferating hepatocytes positive for proliferating cell nuclear antigen (PCNA/cyclin) to analyze the process of liver regeneration in embedded tissues fixed with formaldehyde using an anti-PCNA/cyclin monoclonal antibody. In liver specimens from patients with acute viral hepatitis (AVH) and confluent necrosis, many small basophilic hepatocytes surrounding large clear hepatocytes were positively stained in the areas next to the confluent necrosis. Therefore these small hepatocytes may be daughter cells derived from large clear hepatocytes that probably enter the mitotic cell cycle repeatedly to repair a large necrotic area. In the case of AVH with spotty necrosis, the positively stained hepatocytes were scattered around the necrotic foci. In the liver specimens from patients with chronic active hepatitis, most of the positively stained hepatocytes were located next to the necrotic area. As for cirrhosis of the liver, the number of hepatocytes positive for PCNA/cyclin varied greatly in different pseudolobules, and in the specimens of hepatocellular carcinoma (HCC), the HCC cells positive for PCNA/cyclin were detected throughout the cancer nests.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1346735      PMCID: PMC1886429     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  18 in total

1.  Autoantibody to a nuclear antigen in proliferating cells.

Authors:  K Miyachi; M J Fritzler; E M Tan
Journal:  J Immunol       Date:  1978-12       Impact factor: 5.422

2.  Cyclin/PCNA immunostaining as an alternative to tritiated thymidine pulse labelling for marking S phase cells in paraffin sections from animal and human tissues.

Authors:  P Galand; C Degraef
Journal:  Cell Tissue Kinet       Date:  1989-09

3.  Cell cycle-dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells: subdivision of S phase.

Authors:  J E Celis; A Celis
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

4.  Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues. Comparison with flow cytometric analysis.

Authors:  R L Garcia; M D Coltrera; A M Gown
Journal:  Am J Pathol       Date:  1989-04       Impact factor: 4.307

5.  Expression of hepatocyte growth factor gene in endothelial and Kupffer cells of damaged rat livers, as revealed by in situ hybridization.

Authors:  S Noji; K Tashiro; E Koyama; T Nohno; K Ohyama; S Taniguchi; T Nakamura
Journal:  Biochem Biophys Res Commun       Date:  1990-11-30       Impact factor: 3.575

6.  Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta.

Authors:  R Bravo; R Frank; P A Blundell; H Macdonald-Bravo
Journal:  Nature       Date:  1987 Apr 2-8       Impact factor: 49.962

7.  Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: A new reagent for detection of DNA replication.

Authors:  H G Gratzner
Journal:  Science       Date:  1982-10-29       Impact factor: 47.728

8.  Expression of proliferating cell nuclear antigen (PCNA)/cyclin during the cell cycle.

Authors:  P Kurki; M Vanderlaan; F Dolbeare; J Gray; E M Tan
Journal:  Exp Cell Res       Date:  1986-09       Impact factor: 3.905

9.  Monoclonal antibodies to a nuclear protein (PCNA/cyclin) associated with DNA replication.

Authors:  K Ogata; P Kurki; J E Celis; R M Nakamura; E M Tan
Journal:  Exp Cell Res       Date:  1987-02       Impact factor: 3.905

10.  Changes in the nuclear distribution of cyclin (PCNA) but not its synthesis depend on DNA replication.

Authors:  R Bravo; H Macdonald-Bravo
Journal:  EMBO J       Date:  1985-03       Impact factor: 11.598

View more
  17 in total

1.  WDRPUH, a novel WD-repeat-containing protein, is highly expressed in human hepatocellular carcinoma and involved in cell proliferation.

Authors:  Fabio Pittella Silva; Ryuji Hamamoto; Yusuke Nakamura; Yoichi Furukawa
Journal:  Neoplasia       Date:  2005-04       Impact factor: 5.715

2.  Prognostic value of thymidine phosphorylase activity in liver tissue adjacent to hepatocellular carcinoma.

Authors:  Takahiro Ezaki; Toru Ikegami; Takashi Maeda; Tomomi Yamada; Teruyoshi Ishida; Makoto Hashizume; Yoshihiko Maehara
Journal:  Int J Clin Oncol       Date:  2005-06       Impact factor: 3.402

3.  Expression of proliferation associated antigens and detection of numerical chromosome aberrations in primary human liver tumours: relevance to tumour characteristics and prognosis.

Authors:  M Nolte; M Werner; A Nasarek; H Bektas; R von Wasielewski; J Klempnauer; A Georgii
Journal:  J Clin Pathol       Date:  1998-01       Impact factor: 3.411

4.  Administration of hepatic stimulatory substance alone or with other liver growth factors does not ameliorate acetaminophen-induced liver failure.

Authors:  A Francavilla; A Azzarone; G Carrieri; U Cillo; D Van Thiel; V Subbottin; T E Starzl
Journal:  Hepatology       Date:  1993-03       Impact factor: 17.425

5.  Immunohistochemical location of prothymosin alpha in regenerating human hepatocytes and hepatocellular carcinomas.

Authors:  M Fraga; T García-Caballero; F Domínguez; E Pérez-Becerra; A Beiras; J Forteza
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

6.  Proliferative potential of meningiomas evaluated by proliferating cell nuclear antigen expression.

Authors:  H Nakabayashi; M Sakaguchi; J Katsuyama; A Hakuba
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

Review 7.  Hepatic regeneration and the epithelial to mesenchymal transition.

Authors:  Zeng-Fu Xue; Xiu-Min Wu; Ming Liu
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

8.  Analysis of proliferating biliary epithelial cells in human liver disease using a monoclonal antibody against DNA polymerase alpha.

Authors:  S Seki; H Sakaguchi; N Kawakita; A Yanai; T Kuroki; K Kobayashi
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

9.  Proliferative activity in peripheral and coronary atherosclerotic plaque among patients undergoing percutaneous revascularization.

Authors:  J G Pickering; L Weir; J Jekanowski; M A Kearney; J M Isner
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

10.  Proliferative activity of mixed hyperplastic adenomatous polyp/serrated adenoma in the large intestine, measured by PCNA (proliferating cell nuclear antigen).

Authors:  N Fujishima
Journal:  J Gastroenterol       Date:  1996-04       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.